Mazor Robotics

Mazor Robotics was an Israeli medical-device company focused on robotic and image-guided systems for spinal surgery. Its technology was designed to help surgeons plan and execute procedures involving the spine, including the placement of instruments and implants, by combining preoperative imaging, intraoperative imaging, navigation, and mechanically guided positioning. The company became known for developing one of the earliest commercially available robotic guidance platforms dedicated to spine surgery. The business was founded in 2001 by Professor Moshe Shoham, head of the Medical Robotics Laboratory in the Faculty of Mechanical Engineering at the Technion, and Eli Zehavi, a former engineering executive at Elscint. During its first years, the company operated from the Technion incubator offices known as T3, which supported the transfer of academic and engineering innovations into commercial ventures. It was initially incorporated as M.A.S.O.R. Surgical Technologies and later used the name Mazor Surgical Technologies before adopting Mazor Robotics in 2010. Mazor's first major product was SpineAssist, a bone-mounted mechanical guidance system for spinal procedures. The system was based on the company's SmartAssist technology platform and was intended to improve the accuracy and repeatability of surgical trajectories. SpineAssist received a CE mark in early 2004 and subsequently obtained United States Food and Drug Administration clearance in the same year. The product's European commercialization and United States clearance established Mazor as an early specialist in robotic assistance for spinal surgery. The company developed its next-generation platform, the Renaissance Guidance System, as a successor to SpineAssist. Commercially introduced in 2011, Renaissance provided image-guided planning and mechanical positioning support for spinal procedures. The system was described as offering approximately 1.5 millimeters of accuracy in its FDA 510(k) documentation. Its applications included procedures involving spinal instrumentation, deformity correction, and minimally invasive surgery. In contrast with a fully autonomous surgical robot, Renaissance primarily served as a surgeon-controlled guidance and positioning system. Mazor later expanded its product architecture with MazorX, a table-mounted robotic arm intended for spine surgery. MazorX could function as an open platform for K-wire placement and could integrate with Medtronic's Stealth navigation technology. This development reflected the company's broader shift from a specialized mechanical guidance device toward an integrated surgical-planning, navigation, and robotic-assistance ecosystem. Ori Hadomi became chief executive officer in 2003. Under his leadership, Mazor developed its international commercial presence and advanced the transition from SpineAssist to Renaissance and subsequently to MazorX. The company's scientific profile was also reinforced when Moshe Shoham was elected to the United States National Academy of Engineering in 2014 for contributions to robotic technology for image-guided surgery. Mazor Robotics was acquired by Medtronic in December 2018 in a transaction valued at approximately $1.7 billion. The acquisition brought Mazor's spinal robotics technology into Medtronic's broader spine, navigation, imaging, and surgical-technology portfolio. Following the transaction, Mazor ceased to operate as an independent publicly traded company, while its technologies were incorporated into Medtronic's surgical robotics and navigation activities.

Mazor Robotics originated in Israel's academic and medical-engineering ecosystem. Professor Moshe Shoham, who led the Medical Robotics Laboratory in the Technion's Faculty of Mechanical Engineering, and Eli Zehavi, a former engineering vice president at Elscint, founded the company in 2001. During 2001 and 2002, the young business was based in the Technion's T3 incubator offices, an environment intended to help commercialize innovative technologies for international markets. The company was initially incorporated as M.A.S.O.R. Surgical Technologies and later changed its name to Mazor Surgical Technologies. Its early work centered on the SmartAssist platform, which provided the technological foundation for a mechanically guided approach to spinal surgery. The engineering challenge was not simply to move a robotic mechanism, but to relate preoperative images to intraoperative anatomy and adapt the system to different spinal applications. These applications included deformity procedures and minimally invasive degenerative repairs. Mazor's first commercial product, SpineAssist, was a bone-mounted mechanical guidance system. It received its first CE mark in early 2004 and was subsequently sold in Europe. Later in 2004, the system received FDA clearance in the United States. The company characterized SpineAssist as the first FDA-approved robotic system for spinal surgery and as the first commercially available mechanical guidance system of its type. The regulatory milestones gave Mazor an early position in a specialized but developing segment of surgical robotics. Ori Hadomi, previously chief financial officer of Denex, became Mazor's chief executive officer in 2003. He oversaw the company's development during its transition from a technology-centered start-up to a commercial medical-device business. In 2010, the company adopted the name Mazor Robotics, reflecting the importance of robotics to its identity and product strategy. In June 2011, Mazor commercially launched the Renaissance Guidance System. Renaissance replaced SpineAssist and represented the company's next generation of robotic guidance technology. It supported surgical planning and mechanically guided positioning for spinal procedures, with an FDA 510(k) filing describing accuracy of approximately 1.5 millimeters. The product was intended to support surgeons in procedures involving instrumentation, deformity correction, and minimally invasive techniques rather than to operate independently of the surgical team. Mazor subsequently developed MazorX, a table-mounted active robotic arm for spine surgery. Unlike the earlier bone-mounted guidance approach, MazorX used a table-mounted architecture and could serve as an open platform for K-wire placement. It could also integrate with Medtronic's Stealth navigation system, creating a path toward closer coordination between robotic positioning, navigation, imaging, and surgical planning. The company maintained a strong connection to academic robotics. In February 2014, Moshe Shoham was elected to the National Academy of Engineering in recognition of his contributions to robotic technology for image-guided surgery. This distinction underscored the technical and research background behind Mazor's commercial products. Mazor Robotics remained an independent medical-device company until Medtronic acquired it in December 2018. The transaction was valued at approximately $1.7 billion. The acquisition ended Mazor's independent corporate life and placed its robotic guidance systems within Medtronic's larger spine and surgical-navigation business. Mazor is therefore best understood historically as an independent Israeli spine-robotics pioneer whose technology became part of Medtronic's integrated surgical technology portfolio.

• 2018

  Acquired by Medtronic

  [1]Mazor Roboticsen.wikipedia.org

  Medtronic acquired Mazor Robotics in a transaction valued at approximately $1.7 billion.

• 2014

  Co-founder elected to the National Academy of Engineering

  [1]Mazor Roboticsen.wikipedia.org

  Moshe Shoham was recognized for contributions to robotic technology for image-guided surgery.

• 2011

  Renaissance Guidance System launched

  [1]Mazor Roboticsen.wikipedia.org

  Renaissance was commercially introduced as the successor to SpineAssist.

• 2010

  Company renamed Mazor Robotics

  [1]Mazor Roboticsen.wikipedia.org

  The company changed its name from Mazor Surgical Technologies to Mazor Robotics.

• 2004

  SpineAssist receives European and United States clearances

  [1]Mazor Roboticsen.wikipedia.org

  SpineAssist received a CE mark and later FDA clearance, supporting its commercialization as a robotic guidance system for spinal surgery.

• 2001

  Company founded

  [1]Mazor Roboticsen.wikipedia.org

  Moshe Shoham and Eli Zehavi founded the company to commercialize robotic guidance technology for spinal surgery.

• 2001

  Initial incorporation

  [1]Mazor Roboticsen.wikipedia.org

  The business was initially incorporated under the name M.A.S.O.R. Surgical Technologies.

A specialist medical-technology company positioned around precision, image guidance, and robotic assistance for spinal surgery. Mazor's systems were designed to augment surgeons rather than autonomously perform operations, with emphasis on preoperative planning, accurate instrument trajectories, minimally invasive techniques, and integration with surgical navigation.

• Spine-surgery robotic guidance system · 2004

  SpineAssist

  SpineAssist was Mazor's first major product and a bone-mounted mechanical guidance system for spinal surgery. It used the company's SmartAssist technology to help surgeons plan and guide surgical trajectories. Its development addressed the alignment of preoperative images with intraoperative CT data and the need to adapt robotic guidance to procedures such as deformity correction and minimally invasive degenerative repair. SpineAssist received a CE mark in early 2004 and FDA clearance later that year.

• Image-guided spine-surgery robotic platform · 2011

  Renaissance Guidance System

  Renaissance was introduced as the next generation of Mazor's spinal robotic guidance technology and commercially launched in 2011. It replaced SpineAssist and supported image-based surgical planning together with mechanically guided positioning. The system was designed to assist surgeons during spinal instrumentation and related procedures, with FDA 510(k) materials describing accuracy of approximately 1.5 millimeters. It represented Mazor's move toward a broader and more capable platform for spine surgery.

• Table-mounted robotic arm for spine surgery

  MazorX

  MazorX was a table-mounted active robotic arm designed for spinal procedures. It could be used as an open platform for K-wire placement and could integrate with Medtronic's Stealth navigation technology. The platform extended Mazor's product approach beyond the earlier bone-mounted guidance system and supported closer integration of robotic positioning, navigation, and surgical planning.

• 2018

  Medtronic acquisitionM&A

  Background

  Medtronic sought to expand its capabilities in spinal robotics, surgical navigation, and image-guided procedures.

  Action taken

  Medtronic acquired Mazor Robotics in December 2018 for approximately $1.7 billion.

  Aftermath

  Mazor ceased to operate as an independent company, and its robotic technologies were incorporated into Medtronic's spine and surgical-technology activities.

  Transaction value. $1.7 billion (December 2018)

  Source

• 2011

  Replaced SpineAssist with RenaissanceProduct launch

  Background

  Mazor needed a next-generation platform after its first SpineAssist system established an early commercial and regulatory presence.

  Action taken

  The company commercially launched the Renaissance Guidance System in June 2011.

  Aftermath

  Renaissance became the company's principal spinal robotic guidance platform and formed the basis for later product development.

  Source

• 2010

  Adopted the Mazor Robotics nameStrategy

  Background

  The company had evolved from its original surgical-technology identity into a business centered on robotic guidance for spine surgery.

  Action taken

  It changed its corporate name from Mazor Surgical Technologies to Mazor Robotics.

  Aftermath

  The new name emphasized robotics as the company's principal technological and commercial focus.

  Source

1. 1Mazor Roboticsen.wikipedia.org